Search - tctmd.com

Displaying 1 - 15 of 15

Sort: Relevancy | Date

News Daily News

Reversal of Childhood Overweight May Prevent Later CHD Risks

Todd Neale

December 03, 2025

News Daily News

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

Michael O'Riordan

August 01, 2025

News Conference News HRS 2025

GLP-1 Drugs May Have Role in Secondary Prevention of AF

Todd Neale

April 28, 2025

SUMMIT: Tirzepatide ‘Huge Win’ for HFpEF Patients With Obesity

News Conference News AHA 2024

SUMMIT: Tirzepatide a ‘Huge Win’ for HFpEF Patients With Obesity

Michael O'Riordan

November 16, 2024

News Daily News

Real-world Patients Might Lose More Weight With Tirzepatide vs Semaglutide

Yael L. Maxwell

July 10, 2024

News Daily News

‘Provocative’ Projections See Semaglutide Slashing CV Events in Adults With ASCVD

Todd Neale

June 27, 2024

News Daily News

Bariatric Surgery Reduces Hard Events in Obese Patients With Sleep Apnea

Michael O'Riordan

June 21, 2024

News Daily News

How Mediterranean Diets Might Cut Mortality in Women: New Insights

Yael L. Maxwell

June 05, 2024

News Features

Skyrocketing Popularity Puts GLP-1 Agonists for Weight Loss on Cardiology’s Radar

L.A. McKeown

May 12, 2023

News Daily News

Sugar Substitute Erythritol Linked to Cardiac Risk

Yael L. Maxwell

March 15, 2023

News Conference News SCCT 2019

Imaging, Genes, Wearables: Some Predictions for the Future of Preventive Cardiology

Yael L. Maxwell

July 15, 2019

News Daily News

Sitting Kills, in a Dose-Response Fashion, but Regular Physical Activity Attenuates Risks

Yael L. Maxwell

April 25, 2019

News Daily News

Coronary Microvascular Dysfunction May Be a Marker of CV Risk in Obese Patients

L.A. McKeown

August 09, 2018

News Daily News

Childhood Obesity Can Affect Cardiovascular Risk Even If Resolved by Adulthood

Yael L. Maxwell

April 11, 2018

News Daily News

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

Shelley Wood

December 26, 2017

Advertisement

Reversal of Childhood Overweight May Prevent Later CHD Risks

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

GLP-1 Drugs May Have Role in Secondary Prevention of AF

SUMMIT: Tirzepatide a ‘Huge Win’ for HFpEF Patients With Obesity

Real-world Patients Might Lose More Weight With Tirzepatide vs Semaglutide

‘Provocative’ Projections See Semaglutide Slashing CV Events in Adults With ASCVD

Bariatric Surgery Reduces Hard Events in Obese Patients With Sleep Apnea

How Mediterranean Diets Might Cut Mortality in Women: New Insights

Skyrocketing Popularity Puts GLP-1 Agonists for Weight Loss on Cardiology’s Radar

Sugar Substitute Erythritol Linked to Cardiac Risk

Imaging, Genes, Wearables: Some Predictions for the Future of Preventive Cardiology

Sitting Kills, in a Dose-Response Fashion, but Regular Physical Activity Attenuates Risks

Coronary Microvascular Dysfunction May Be a Marker of CV Risk in Obese Patients

Childhood Obesity Can Affect Cardiovascular Risk Even If Resolved by Adulthood

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content